Erudio Healtherudio.com
Drug
Vibostolimab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying vibostolimab: KEYVIBE-008. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| KEYVIBE-008 NCT05224141 · Merck Sharp & Dohme LLC | first-line extensive-stage small cell lung cancer | Phase 3 | 83 | 17 | Focused | Nov 15, 2026 | Preview |